<DOC>
	<DOCNO>NCT00954824</DOCNO>
	<brief_summary>People overweight increase risk heart disease . Being overweight heart disease link involve inflammation . Inflammation refer body 's first line defense infection injury . Metabolic change cholesterol , triglyceride ( fat blood ) sugar blood cause inflammation similar people overweight . The investigator wish examine effect inflammation metabolic change may lead heart disease .</brief_summary>
	<brief_title>Inflammation Metabolic Syndrome Humans</brief_title>
	<detailed_description>This study single site , open-label , `` baseline-controlled '' ( pre LPS saline period ) study examine pro-atherosclerotic metabolic response safety response single administration low-dose ( 3 ng/kg ) endotoxin ( LPS ) 20 additional non-metabolic syndrome participant : 10 healthy overweight 10 healthy lean counterpart ( 20 non-metabolic syndrome participant study first phase ) , 40 subject metabolic syndrome . We continue use approach whereby `` metabolic syndrome '' subject recruit key metabolic syndrome abnormality sensitive insulin resistance compare non-metabolic syndrome group , although `` metabolic syndrome '' subject may fulfill traditional NCEP criterion syndrome .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>1 . Men nonpregnant/lactating woman age 18 40 2 . Subjects must able give write informed consent willing comply studyrelated procedure . 3 . BMI &gt; 18 &lt; 24 BIA &lt; 15 % fat men , &lt; 25 % fat woman , diagnosis NCEP metabolic syndrome define , OR 4 . BMI &gt; 26 &lt; 30 BIA &gt; 15 % fat men , &gt; 25 % fat woman , diagnosis NCEP metabolic syndrome , OR 5 . BMI &gt; 18 &lt; 30 metabolic syndrome abnormality define . The modified NCEP Metabolic Syndrome criterion follow abdominal obesity , waist circumference : men &gt; = 37 ( 94 cm ) , woman &gt; = 31 ( 80 cm ) fast triglyceride &gt; 150 mg/dL HDL cholesterol &lt; 40 mg/dL men ; HDL cholesterol &lt; 50 mg/dL woman Blood pressure &gt; 130/ &gt; 85 mmHg untreated patient Fasting glucose &gt; 100 mg/dL , less 126 mg/dL 6 . For inclusion `` metabolic syndrome '' group , follow additional criterion must fulfil : Three NCEP criterion define . OR Two NCEP criterion AND TG/HDL ratio &gt; 3.0 . 1 . Known atherosclerotic cardiovascular disease , include coronary disease , cerebrovascular disease , peripheral vascular disease . 2 . History diabetes mellitus . 3 . A plasma glucose great 200 mg/dL 2 hour blood draw oral glucose tolerance test . 4 . History nonskin malignancy within previous 5 year . 5 . Renal insufficiency define creatinine &gt; = 1.5 mg/dl visit 1 ( grade 1 NIH 's Common Toxicity Criteria ( CTC ) , version 2.0 , 4/30/99 ) . 6 . History liver disease ALT , AST , ALK Phosphatase Gamma GT normal limit define HUP William Pepper Clinical Laboratory visit 1 . 7 . Elevated ( &gt; 1.5x ULN ; grade 1 , CTC , 4/30/99 ) Total Bilirubin LDH visit 1 . 8 . Men consume &gt; 14 alcoholic drink per week &gt; 4 alcoholic drink per occasion ( AMA/NIAAA criteria `` risk '' usage level ) . 9 . Women consume &gt; 7 alcoholic drink per week &gt; 3 alcoholic drink per occasion ( AMA/NIAAA criteria `` risk '' usage level ) . 10 . Total white blood cell count normal limit define HUP William Pepper Clinical Laboratory prior baseline visit . 11 . Hemoglobin normal limit ( gender specific ) define HUP William Pepper Clinical Laboratory prior baseline visit . 12 . Any medical condition abnormal laboratory value judge clinically significant investigator . 13 . Any major active rheumatologic , pulmonary , dermatologic disease inflammatory condition minor active infection . 14 . History HIV positive . 15 . First degree family history premature cardiovascular disease event ( father brother diagnose 55 year age ; mother sister diagnose 65 year age ) . 16 . Patients undergone organ transplant . 17 . Individuals currently use tobacco product do previous 30 day . 18 . Treatment aspirin , NSAIDs , COX2 inhibitor , steroid immunomodulatory therapy 2 week prior screen visit 19 . Treatment statin , fibrates niacin 4 week prior screen visit . 20 . Current daily use Vitamin C &gt; 1000 mg , Beta carotene &gt; 1000 IU , vitamin A &gt; 5000 IU , vitamin E &gt; 400 IU , selenium &gt; 200 mcg . 21 . Positive urine pregnancy screen visit . 22 . Participation another clinical trial within previous 6 week prior screen visit . 23 . Poorly control blood pressure ( BP &gt; 160/100 ) antihypertensive medication . 24 . For subject nonmetabolic syndrome group ; diagnosis metabolic syndrome use NCEP ATPIII criterion . 25 . For subject `` metabolic syndrome '' group ; abnormal Bruce protocol cardiac exercise stress test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>